AMRI out to win customers back; Clinart MENA pursues CRO expansion in Middle East; Xceleron raises cash;

> AMRI says it is out to win back customers now that the FDA has given it a clean bill of health for its sterile fill-finish facility in Massachusetts. Report

> New financial backing along with a newly named CEO are bolstering Clinart MENA's plans to develop the CRO market in the Middle East. Story

> Xceleron has raised $2.4 million and hatched plans to relocate senior analytics workers from the U.K. to its new facility in Germantown, MD. Release

> In a new licensing deal, Bend Research says it will make its proprietary spray-dried dispersion technology available to Eli Lilly. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.